2.1. Synthesis
All reagents were purchased from either Acros, Sigma-Aldrich or Maclin and used without further purification. Solvents were purified by standard methods. Substance purity and the reaction process were monitored by TLC on Merck UV 254 plates and visualized by exposure to UV with a VL-6.LC lamp (Vilber, Marne-la-Vallée, France).
Flash chromatography was done using SepaBeanTM machine 2; detector: DAD variable UV (254 and 280 nm); flow range 5 mL/min; gradient H2O→AcN; column type: Santai Technologies, Inc., SepaFlashTM SW004 Bonded, spherical C18, 20-45 μm, 100 Å, item number: SW-5222-004-SP.
Melting points were measured using the OIptimelt MPA100 melting point apparatus (Stanford Research Systems, Sunnyvale, CA, USA).
1H and 13C NMR spectra were recorded on Bruker Avance 400 Nanobay (Bruker Corporation, Billerica, MA, USA) with signals from residual protons of DMSO-d6 or CDCl3 as internal standard.
ATR-IR spectra and IR spectra in KBr pellets were collected using a Bruker Vector-22 spectrometer (Bruker Corporation, Billerica, MA, USA).
High-resolution mass spectra with electrospray ionization (HRESI MS) were obtained on an Agilent iFunnel 6550 Q-TOF LC/MS (Agilent Technologies, Santa Clara, CA, USA). Carrier gas: nitrogen, temperature 300 °C, carrier flow rate 12.l × min−1, nebulizer pressure 275 kPa, funnel voltage 3500 V, capillary voltage 500 V, total ion current recording mode, 100–3000 m/z mass range, scanning speed 7 spectra × s−1.
Data set for single crystal
5 was collected on a Rigaku XtaLab Synergy S instrument with a HyPix detector and a PhotonJet microfocus X-ray tube using Cu Kα (1.54184 Å) radiation at room temperature. Images were indexed and integrated using the CrysAlisPro data reduction package. Data were corrected for systematic errors and absorption using the ABSPACK module: numerical absorption correction based on Gaussian integration over a multifaceted crystal model and empirical absorption correction based on spherical harmonics according to the point group symmetry using equivalent reflections. The GRAL module was used for analysis of systematic absences and space group determination. The structure was solved by direct methods using SHELXT [
27] and refined by the full-matrix least-squares on F
2 using SHELXL [
28]. Non-hydrogen atoms were refined anisotropically. The hydrogen atoms were inserted at the calculated positions and refined as riding atoms. The figures were generated using Mercury 4.1 [
29] program. Crystals were obtained by slow evaporation method.
Prop-2-yn-1-yl 2-(3-oxo-6-(prop-2-yn-1-yloxy)-3
H-xanthen-9-yl)benzoate 2 [
30], methyl 2-(6-methoxy-3-oxo-3
H-xanthen-9-yl)benzoate 3[
31], 3’-hydroxy-6’-methoxy-3
H-
spiro[isobenzofuran-1,9’-xanthen]-3-one 4 [
32], 3-azido-
N,N-dimethylpropan-1-amine 7 [
33] were synthesized according to the literature procedures.
The synthesis of prop-2-yn-1-yl 2-(6-methoxy-3-oxo-3H-xanthen-9-yl)benzoate 5
To a solution of 3’-hydroxy-6’-methoxy-3H-spiro[isobenzofuran-1,9’-xanthen]-3-one 4 (1.5 g, 4.3 mmol, 1 eq.) in 20 ml of dry DMF was added K2CO3 (0.89 g, 6.45 mmol, 1.5 eq.). The mixture was stirred at rt for 30 min, then propargyl bromide (0.62 g, 5.2 mol, 1.2 eq.) was added. The mixture was stirred for 24 hours at rt, and the resultant product was concentrated under vacuum. The residue was suspended in H2O and the formed precipitate was filtered off. After recrystallization in benzene the product 5 was obtained as orange crystals. Yield 1.42 g, 85%. Mp=214 oC.
1H NMR (400 MHz, CDCl3, 25 oC) δ, ppm: 2.33 (t, J = 6.9 Hz, 1H, -C≡CH), 3.92 (s, 3H, -OCH3), 4.59 (dABq, 2H, ΔδAB = 0.07, JAB = 12.2 Hz, J = 2.4 Hz, 2H, -OCH2-), 6.45 (s, 1H, ArH), 6.54 (d, J = 9.7, 1H, ArH), 6.74 (d, J = 9.0 Hz, 1H, ArH), 6.80-6.92 (m, 2H, ArH), 6.96 (d, J = 2.4 Hz, 1H, ArH), 7.34 (d, J = 7.2 Hz, 1H, ArH), 7.76 (t, J = 7.4 Hz, 1H, ArH), 7.69 (t, J = 7.6 Hz, 1H, ArH), 8.27 (d, J = 7.8 Hz, 1H, ArH). 13C NMR (101 MHz, CDCl3, 25 oC) δ, ppm: 52.9, 56.1, 56.5, 75.5, 100.5, 105.9, 113.6, 113.6, 114.9, 117.9, 128.9, 129.8, 130.2, 130.3, 130.8, 131.5, 133.2, 134.9, 149.7, 154.5, 159.1, 164.2, 164.6, 185.9. IR (KBr) ν max cm-1: 3294 (C≡CH), 2123, 1726 (C=O), 1643, 1599, 1545, 1518, 1481, 1464, 1417, 1379, 1344, 1280, 1269, 1253, 1211, 1130, 1107, 758. HRESI MS (m/z) [M + H]+: calcd. for C24H17O5+ 385.1076, found: 385.1080. (Fig. S1 in the Supporting Information).
Crystal Data for C24H16O5 (M =384.37 g/mol): monoclinic, space group P21/c (no. 14), a = 14.5495(3) Å, b = 8.7385(2) Å, c = 14.4494(3) Å, β = 99.790(2)°, V = 1810.36(7) Å3, Z = 4, T = 100.0(7) K, μ(Cu Kα) = 0.815 mm-1, Dcalc = 1.410 g/cm3, 12169 reflections measured (6.164° ≤ 2Θ ≤ 151.978°), 3662 unique (Rint = 0.0265, Rsigma = 0.0241) which were used in all calculations. The final R1 was 0.0395 (I > 2σ(I)) and wR2 was 0.1039 (all data). CCDC number 2358771.
General procedure for synthesis of 1,2,3-triazoles 8-9
To a solution of azide 7 (1 mmol, 1 eq. in case of 5 or 2 mmol, 2 eq. in case of 2) in 5 ml of THF was added NEt3 (0.5 ml) following by of alkynes 2 or 5 (1 mmol, 1eq.) and CuI (0.1 mmol, 0.1 eq.). The reaction mixture was stirred at rt in inert atmosphere for 10-14 h. The completion of the reaction was determined by TLC (CHCl3:MeOH=10:1). The reaction mixture was evaporated, diluted with CHCl3 and filtered through amberlite IRA-67®. After evaporation in vacuo the product was obtained as vitreous oil.
(1-(3-(Dimethylamino)propyl)-1H-1,2,3-triazol-4-yl)methyl 2-(6-((1-(3-(dimethylamino)propyl)-1H-1,2,3-triazol-4-yl)methoxy)-3-oxo-3H-xanthen-9-yl)benzoate 8
Yield 0.33 g, 66%. 1H NMR (400 MHz, CDCl3, 25 oC) δ, ppm: 1.98 (p, J = 6.9 Hz, 2H, -CH2-), 2.07 (p, J = 6.9 Hz, 2H, -CH2-), 2.18 (s, 6H, 2*N-CH3), 2.20 (s, 6H, 2*N-CH3), 2.23 – 2.29, (m, 4H, 2* -NCH2-), 4.27 – 4.42 (m, 2H, -NCH2-), 4.28 – 4.40 (m, 2H, -NCH2-), 5.11 (ABq, 2H, ΔδAB = 0.07, JAB = 12.6 Hz, 2H, -OCH2-), 5.32 (s, 2H, -OCH2-), 6.39 (s, 1H, ArH), 6.49 (d, J = 9.7 Hz, 1H, ArH), 6.76 – 6.81 (m, 2H, ArH), 6.81-6.89 (m, 1H, ArH), 7.05 (s, 1H, ArH), 7.25 (s, 1H, TrzH), 7.62 – 7.77 (m, 3H, ArH+TrzH), 8.25 (d, J = 7.8, 1.5 Hz, 1H, ArH). 13C NMR (101 MHz, CDCl3, 25 oC) δ, ppm: 28.1, 28.2, 45.4, 45.4, 48.2, 48.4, 55.8, 55.8, 58.5, 62.7, 76.8, 77.2, 77.5, 101.6, 105.7, 113.8, 117.8, 123.7, 123.9, 129.1, 129.9, 129.9, 130.2, 130.3, 130.6, 131.5, 132.9, 134.4, 142.6, 158.9, 162.7, 165.3, 185.6. IR (KBr) ν max cm-1: 3422, 1718 (C=O), 1641, 1597, 1506, 1381, 1344, 1280, 1253, 1209, 1109, 1003, 852, 760. HRESI MS (m/z) [M + H]+: calcd. for C36H41N8O5+: 665.3200, found: 665.3200. (Fig. S2 in the Supporting Information).
(1-(3-(Dimethylamino)propyl)-1H-1,2,3-triazol-4-yl)methyl 2-(6-methoxy-3-oxo-3H-xanthen-9-yl)benzoate 9
Yield 0.4 g, 78 %. 1H NMR (400 MHz, CDCl3, 25 oC) δ, ppm: 1.98 (t, J = 6.9 Hz, 2H, -CH2-), 2.19 (m, 8H, 2* NCH3, -CH2-), 3.93 (s, 3H, -OCH3), 4.29 – 4.38 (m, 2H, -NCH2-), 5.14 (ABq, 2H, ΔδAB = 0.07, JAB = 12.5 Hz, 2H, -OCH2-), 6.40 (s, 1H, ArH), 6.49 (d, J = 9.8 Hz, 1H, ArH), 6.72 (dd, J = 8.9, 2.5 Hz, 1H, ArH), 6.80 – 6.89 (m, 2H, ArH), 6.84 (dd, J = 18.7, 9.3 Hz, 1H, ArH), 7.30 (d, J = 5.3 Hz, 2H, ArH + TrzH), 7.67 (t, J = 7.1 Hz, 1H, ArH), 7.74 (t, J = 6.8 Hz, 1H, ArH), 8.25 (d, J = 6.8 Hz, 1H, ArH). 13C NMR (101 MHz, CDCl3, 25 oC) δ, ppm: 28.1, 45.4, 48.1, 55.8, 56.1, 58.5, 100.4, 105.6, 113.5, 114.8, 117.5, 123.9, 128.9, 129.8, 130.2, 130.3, 130.5, 131.4, 132.9, 134.4, 141.4, 150.1, 154.3, 158.9, 164.2, 165.3, 185.5. IR (KBr) ν max cm-1: 3422, 2947, 1720 (C=O), 1643, 1599, 1514, 1464, 1381, 1346, 1280, 1267, 1255, 1211, 1107, 1076, 1026, 852, 758. HRESI MS (m/z) [M + H]+: calcd. for C29H29N4O5+: 513.2138, found: 513.2139. (Fig. S3 in the Supporting Information).
General procedure for the synthesis of ammonium salts 10ab, 11ab
To solution of 1,2,3-triazole (0.3 mmol) in 5 ml of fresh distilled MeCN was added alkylbromide (2 eq. in cases of 8 or 1 eq. in case of 9). The reaction mixture was stirred under reflux for 15-30 h and the completion of the reaction was determined by HRESI MS. After evaporation of solvent the product was concentrated under reduced pressure. The residue was purified by flesh chromatography (H2O:MeOH 100:0-0:100) to afford pure product.
N-(3-(4-(((2-(6-((1-(3-(butyldimethylammonio)propyl)-1H-1,2,3-triazol-4-yl)methoxy)-3-oxo-3H-xanthen-9-yl)benzoyl)oxy)methyl)-1H-1,2,3-triazol-1-yl)propyl)-N,N-dimethylbutan-1-aminium bromide 10a
Was synthesized in 20 h. Yield 0.239 g, 85%.
1H NMR (400 MHz, CDCl
3, 25
oC) δ, ppm: 0.81 – 0.93 (m, 6H, 2*CH
3), 1.10-1.17 (m, 2H, CH
2), 1.26-1.36 (m, 4H, 2*- CH
2), 1.52-1.63 (m, 2H, 2*- CH
2), 1.88 (s, 10H, -CH
2-), 2.33 – 2.37 (m, 2H, -CH
2-), 2.42 – 2.51 (m, 2H, -CH
2-), 3.08 (s, 6H, 2*N-CH
3), 3.13 (s, 6H, 2*N-CH
3), 3.18 – 3.23 (m, 2H, -CH
2-), 3.59 (t,
J = 5.1 Hz, 2H, -CH
2-), 4.27 – 4.45 (m, 2H, -CH
2Trz-), 4.49 – 4.55 (m, 2H, -CH
2Trz-), 4.96 (ABq, 2H, Δδ
AB = 0.07,
JAB = 12.5 Hz, 2H, -OCH
2-), 5.25 (s, 2H, -OCH
2-), 6.23 (s, 1H, ArH), 6.33 (d,
J = 9.7 Hz, 1H, ArH), 6.66 (d,
J = 8.5 Hz, 1H, ArH), 6.71-6.79 (m, 2H, ArH), 7.03 (d,
J = 2.4 Hz, 1H, ArH), 7.21 (d,
J = 7.2 Hz, 2H, ArH), 7.35 (s, 1H, TrzH), 7.61 (t,
J = 7.1 Hz, 1H, ArH), 7.65 (t,
J = 7.8 Hz, 1H, ArH), 8.15 (d,
J = 9.4 Hz, 1H, ArH), 8.38 (s, 1H, TrzH).
13C NMR (101 MHz, CDCl
3, 25
oC) δ, ppm: 1.4, 1.6, 1.8, 1.9, 2.2, 2.4, 13.9, 14.5, 19.9, 23.0, 24.8, 29.7, 30.0, 32.2, 51.4, 58.4, 62.0, 65.0, 101.6, 105.5, 114.6, 115.3, 116.9, 117.8, 125.1, 129.4, 130.3, 130.7, 130.9, 131.7, 133.3, 134.1, 141.6, 142.8, 151.2, 154.5, 159.4, 163.2, 165.6, 185.7. IR (KBr) ν
max cm
-1: 3414, 2961, 2928, 1720 (C=O), 1641, 1597, 1502, 1464, 1380, 1346, 1282, 1253, 1211, 1111, 1043, 945. HRESI MS (
m/
z) [M]
2+: calcd. for C
44H
58N
8O
52+: 389.2260, found: 389.2261. (
Fig. S4 in the Supporting Information).
N-(3-(4-(((2-(6-((1-(3-(dimethyl(tetradecyl)ammonio)propyl)-1H-1,2,3-triazol-4-yl)methoxy)-3-oxo-3H-xanthen-9-yl)benzoyl)oxy)methyl)-1H-1,2,3-triazol-1-yl)propyl)-N,N-dimethyltetradecan-1-aminium bromide 10b
Was synthesized in 30 h. Yield 0.270 g, 74%.
1H NMR (400 MHz, CDCl
3, 25
oC) δ, ppm: 0.85 (t,
J = 6.7 Hz, 6H, 2*CH
3), 1.21 (s, 48H, -CH
2-), 1.71 (s, 4H, -CH
2-), 2.50 – 2.53 (m, 2H, -CH
2-), 2. 58 – 2.69 (m, 2H), 3.30 (s, 6H, 2*N-CH
3), 3.35 (s, 6H, 2*N-CH
3), 3.39 – 3.49 (m, 4H, 2*-CH
2-), 3.83 – 3.92 (m, 4H, 2*-CH
2-), 4.49 – 4.62 (m, 2H, -CH
2Trz-), 4.72 (t,
J = 6.9 Hz, 2H, -CH
2Trz-), 4.98 (ABq, 2H, Δδ
AB = 0.1,
JAB = 12.5 Hz, 2H, -OCH
2-), 5.32- 5.35 (m, 2H, -OCH
2-), 6.36 (s, 1H, ArH), 6.46 (d,
J = 9.9 Hz, 1H, ArH), 6.76 (d,
J = 9.0 Hz, 1H, ArH), 6.79-6.86 (m, 2H, ArH), 7.14 – 7.19 (m, 1H, ArH), 7.25 (s, 1H, TrzH), 7.49 (d, 1H, ArH), 7.63 – 7.76 (m, 2H, ArH), 8.23 (d,
J = 7.8 Hz, 1H, ArH), 8.59 (s, 1H, TrzH).
13C NMR (101 MHz, CDCl
3, 25
oC) δ, ppm: 14.2, 22.8, 22.9, 24.0, 24.1, 26.4, 26.6, 28.8, 29.3, 29.5, 29.6, 29.7, 29.8, 29.9, 32.0, 46.9, 47.2, 50.9, 51.3, 58.2, 61.7, 61.8, 62.5, 65.4, 101.5, 105.1, 114.8, 115.1, 117.5, 124.7, 125.8, 129.3, 130.1, 130.2, 130.3, 130.8, 131.6, 133.7, 141.2, 142.5, 151.6, 154.3, 158.9, 163.2, 165.3, 184.7. IR (KBr) ν max cm
-1: 3418, 2924, 2880, 2853, 1720 (C=O), 1643, 1597, 1506, 1468, 1381, 1280, 1253, 1211, 1109, 758. HRESI MS (
m/
z) [M]
2+: calcd. for C
64H
98N
8O
52+: 529.3825, found: 529.3882. (
Fig. S5 in the Supporting Information).
N-(3-(4-(((2-(6-methoxy-3-oxo-3H-xanthen-9-yl)benzoyl)oxy)methyl)-1H-1,2,3-triazol-1-yl)propyl)-N,N-dimethylbutan-1-aminium bromide 11a
Was synthesized in 15 h. Yield 0.16 g, 79%.
1H NMR (400 MHz, DMSO-d
6, 25
oC) δ, ppm: 0.92 (t,
J = 7.3 Hz, 3H, CH
3), 1.28 (h,
J = 7.4 Hz, -СH
2-), 1.59 (p,
J = 8.3 Hz, 2H, -CH
2-), 2.17 – 2.29 (m, 2H, -NCH
2-), 3.01 (s, 6H), 3.21 – 3.29 (m, 4H, -CH
2-), 3.92 (s, 3H, -OCH
3), 4.36 (t,
J = 7.1 Hz, 2H, -NCH
2-), 5.07 (ABq, 2H, Δδ
AB = 0.09,
JAB = 12.5 Hz, 2H, -OCH
2-), 6.19 (d,
J = 1.9 Hz, 1H, ArH), 6.34 (d,
J = 9.7Hz, 1H, ArH), 6.74 (d,
J = 9.7 Hz, 1H, ArH), 6.82 (d,
J = 8.9 Hz, 1H, ArH), 6.79 – 6.86 (m, 2H, ArH), 7.18 (d,
J = 2.5 Hz, 1H, ArH), 7.49 (d,
J = 7.5 Hz, 1H, ArH), 7.49 (t,
J = 7.7 Hz, 1H, ArH), 7.87 (t,
J = 7.7 Hz, 1H, ArH), 7.92 (s, 1H, TrzH), 8.18 (d,
J = 9.3 Hz, 1H, ArH).
13C NMR (101 MHz, DMSO-d
6, 25
oC) δ, ppm: 13.5, 19.1, 22.9, 23.6, 46.4, 50.2, 56.3, 57.9, 60.0, 62.9, 100.5, 104.5, 113.4, 114.3, 116.7, 124.8, 128.9, 129.3, 129.5, 130.1, 130.7, 133.3, 133.6, 140.8, 149.6, 153.6, 158.3, 163.9, 164.7, 183.8. IR (KBr) ν
max cm
-1: 3418, 2961, 1720 (C=O), 1643, 1599, 1508, 1479, 1383, 1346, 1282, 1255, 1215, 1109, 854, 760. HRESI MS (
m/
z) [M ]
+: calcd. for for C
33H
37N
4O
5+: 569.2758, found: 569.2754. (
Fig. S6 in the Supporting Information).
N-(3-(4-(((2-(6-methoxy-3-oxo-3H-xanthen-9-yl)benzoyl)oxy)methyl)-1H-1,2,3-triazol-1-yl)propyl)-N,N-dimethyltetradecan-1-aminium bromide 11b
Was synthesized in 30 h. Yield 0.194 g, 82%.
1H NMR (400 MHz, DMSO-d
6, 25
oC) δ, ppm: 0.83 (t,
J = 6.7 Hz, 3H, CH
3), 1.23 (s, 24H, 12*-СH
2-), 1.53 – 1.62 (m, 2H, -NCH
2-), 2.18 – 2.28 (m, 2H, -NCH
2-), 3.00 (s, 6H, -N(CH
3)
2-), 3.19 – 3.32 (m, 4H, -CH
2-), 3.92 (s, 3H, -OCH
3), 4.35 (t,
J = 7.1 Hz, 2H, -NCH
2-), 5.07 (ABq, 2H, Δδ
AB = 0.09,
JAB = 12.5 Hz, 2H, -OCH
2-), 6.18 (d,
J = 2.0 Hz, 1H, ArH), 6.33 (d,
J = 9.7 Hz, 1H, ArH), 6.74 (d,
J = 9.8 Hz, 1H, ArH), 6.79-6.91 (m, 2H, ArH), 7.18 (d,
J = 2.4 Hz, 1H, ArH), 7.49 (d,
J = 6.5 Hz, 1H, ArH), 7.78 (t,
J = 6.5 Hz, 1H, ArH), 7.87 (t,
J = 6.5 Hz, 1H, ArH), 7.91 (s, 1H, TrzH), 8.18 (d,
J = 7.9 Hz, 1H, ArH).
13C NMR (101 MHz, DMSO-d
6, 25
oC): δ, ppm: 13.9, 21.6, 22.1, 25.7, 28.5, 28.7, 28.8, 28.9, 29.0, 31.2, 46.4, 50.2, 56.3, 57.9, 60.0, 63.1, 100.5, 104.5, 113.4, 114.2, 116.7, 124.7, 128.8, 129.2, 129.5, 130.2, 130.6, 130.7, 133.3, 133.6, 140.8, 149.6, 153.6, 158.2, 163.9, 164.7, 183.8. IR (KBr) ν
max cm
-1: 3422, 2924, 2853, 1720 (C=O), 1643, 1599, 1512, 1466, 1381, 1346, 1280, 1255, 1213, 1107, 1024, 854, 758, 601. HRESI MS (
m/
z) [M]
+: calcd. for C
43H
57N
4O
5+: 709.4323, found: 709.4324. (
Fig. S7 in the Supporting Information).